Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frohlich

Showing results (431-440 of 1,609) with videos related to

Pageof 161
Sort By:
The American Journal of Cardiology|October 22, 1979
Is arterial pressure the sole factor responsible for hypertensive cardiac hypertrophy?E D Frohlich, R C Tarazi
Current Opinion in Investigational Drugs (London, England : 2000)|April 9, 2005
Plant sterols and their role in combined use with statins for lipid loweringLena Normén, Daniel Holmes, Jiri Frohlich
Chemical Communications (Cambridge, England)|February 23, 2005
Catechol imine ligands: from helicates to supramolecular tetrahedraMarkus Albrecht, Ingo Janser, Roland Frohlich
Clinical Chemistry|February 28, 2002
Can measurement of serum apolipoprotein B replace the lipid profile monitoring of patients with lipoprotein disorders?Saman Miremadi, Allan Sniderman, Jiri Frohlich
Nature|December 22, 2007
After a dozen years of progress the origin of angiosperms is still a great mysteryMichael W Frohlich, Mark W Chase
American Journal of Physiology. Heart and Circulatory Physiology|July 11, 2006
Improvements in clinical outcomes with the use of angiotensin-converting enzyme inhibitors: cross-fertilization between clinical and basic investigationMarc A Pfeffer, Edward D Frohlich
Chest|May 1, 1990
One-year longitudinal study of a no-smoking policy in a medical institutionL G Hudzinski, E D Frohlich
Current Therapeutic Research, Clinical and Experimental|March 1, 1976
Comparison of the antihypertensive effectiveness of guanadrel and guanethidineS G Chrysant, E D Frohlich
Elife|December 28, 2017
Stochastic resonance mediates the state-dependent effect of periodic stimulation on cortical alpha oscillationsJérémie Lefebvre, Axel Hutt, Flavio Frohlich
Circulation|January 1, 1987
Is reversal of cardiac hypertrophy a desirable goal of antihypertensive therapy?R C Tarazi, E D Frohlich
Pageof 161

Showing results (431-440 of 1,609) with videos related to

Sort By:
Pageof 161
The American Journal of Cardiology|October 22, 1979
Is arterial pressure the sole factor responsible for hypertensive cardiac hypertrophy?E D Frohlich, R C Tarazi
Current Opinion in Investigational Drugs (London, England : 2000)|April 9, 2005
Plant sterols and their role in combined use with statins for lipid loweringLena Normén, Daniel Holmes, Jiri Frohlich
Chemical Communications (Cambridge, England)|February 23, 2005
Catechol imine ligands: from helicates to supramolecular tetrahedraMarkus Albrecht, Ingo Janser, Roland Frohlich
Clinical Chemistry|February 28, 2002
Can measurement of serum apolipoprotein B replace the lipid profile monitoring of patients with lipoprotein disorders?Saman Miremadi, Allan Sniderman, Jiri Frohlich
Nature|December 22, 2007
After a dozen years of progress the origin of angiosperms is still a great mysteryMichael W Frohlich, Mark W Chase
American Journal of Physiology. Heart and Circulatory Physiology|July 11, 2006
Improvements in clinical outcomes with the use of angiotensin-converting enzyme inhibitors: cross-fertilization between clinical and basic investigationMarc A Pfeffer, Edward D Frohlich
Chest|May 1, 1990
One-year longitudinal study of a no-smoking policy in a medical institutionL G Hudzinski, E D Frohlich
Current Therapeutic Research, Clinical and Experimental|March 1, 1976
Comparison of the antihypertensive effectiveness of guanadrel and guanethidineS G Chrysant, E D Frohlich
Elife|December 28, 2017
Stochastic resonance mediates the state-dependent effect of periodic stimulation on cortical alpha oscillationsJérémie Lefebvre, Axel Hutt, Flavio Frohlich
Circulation|January 1, 1987
Is reversal of cardiac hypertrophy a desirable goal of antihypertensive therapy?R C Tarazi, E D Frohlich
Pageof 161